BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang Y, Nguyen TM, Zhang XO, Wang L, Phan T, Clohessy JG, Pandolfi PP. Optimized RNA-targeting CRISPR/Cas13d technology outperforms shRNA in identifying functional circRNAs. Genome Biol 2021;22:41. [PMID: 33478577 DOI: 10.1186/s13059-021-02263-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 29.0] [Reference Citation Analysis]
Number Citing Articles
1 Qiu Y, Chen Y, Agbede O, Eshaghi E, Peng C. Circular RNAs in Epithelial Ovarian Cancer: From Biomarkers to Therapeutic Targets. Cancers 2022;14:5711. [DOI: 10.3390/cancers14225711] [Reference Citation Analysis]
2 Wu N, Li F, Yang W, Du WW, Awan FM, Zhang C, Lyu J, Misir S, Zeng K, Eshaghi E, Yang BB. Silencing mouse circular RNA circSlc8a1 by circular antisense cA-circSlc8a1 induces cardiac hepatopathy. Molecular Therapy 2022. [DOI: 10.1016/j.ymthe.2022.10.005] [Reference Citation Analysis]
3 Lv S, Zhao X, Ma X, Zou Q, Li N, Yan Y, Sun L, Song T. Efficient and reversible Cas13d-mediated knockdown with an all-in-one lentivirus-vector. Front Bioeng Biotechnol 2022;10:960192. [DOI: 10.3389/fbioe.2022.960192] [Reference Citation Analysis]
4 Bot JF, van der Oost J, Geijsen N. The double life of CRISPR-Cas13. Curr Opin Biotechnol 2022;78:102789. [PMID: 36115160 DOI: 10.1016/j.copbio.2022.102789] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhou J, Chen Y, He M, Li X, Wang R. Role of Circular RNAs in Pulmonary Fibrosis. Int J Mol Sci 2022;23:10493. [PMID: 36142402 DOI: 10.3390/ijms231810493] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Li S, Wu H, Chen LL. Screening circular RNAs with functional potential using the RfxCas13d/BSJ-gRNA system. Nat Protoc 2022. [PMID: 35831613 DOI: 10.1038/s41596-022-00715-5] [Reference Citation Analysis]
7 Kumar S, Fry LE, Wang JH, Martin KR, Hewitt AW, Chen FK, Liu GS. RNA-targeting strategies as a platform for ocular gene therapy. Prog Retin Eye Res 2022;:101110. [PMID: 35840489 DOI: 10.1016/j.preteyeres.2022.101110] [Reference Citation Analysis]
8 Liu CX, Chen LL. Circular RNAs: Characterization, cellular roles, and applications. Cell 2022;185:2016-34. [PMID: 35584701 DOI: 10.1016/j.cell.2022.04.021] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 14.0] [Reference Citation Analysis]
9 Nielsen AF, Bindereif A, Bozzoni I, Hanan M, Hansen TB, Irimia M, Kadener S, Kristensen LS, Legnini I, Morlando M, Jarlstad Olesen MT, Pasterkamp RJ, Preibisch S, Rajewsky N, Suenkel C, Kjems J. Best practice standards for circular RNA research. Nat Methods 2022. [PMID: 35618955 DOI: 10.1038/s41592-022-01487-2] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
10 Li Z, Li Z, Cheng X, Wang X, Ma S, Wang S, Lu Z, Zhang H, Zhao W, Chen Z, Yao Y, Chao L, Li W, Fei T. Intrinsic RNA targeting constrains the utility of CRISPR-Cas13 systems.. [DOI: 10.1101/2022.05.14.491940] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Almatroudi A. Non-Coding RNAs in Tuberculosis Epidemiology: Platforms and Approaches for Investigating the Genome's Dark Matter. Int J Mol Sci 2022;23:4430. [PMID: 35457250 DOI: 10.3390/ijms23084430] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Mori S, Nakamura T. Redeployment of odontode gene regulatory network underlies dermal denticle formation and evolution in suckermouth armored catfish. Sci Rep 2022;12:6172. [PMID: 35418659 DOI: 10.1038/s41598-022-10222-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Gupta R, Ghosh A, Chakravarti R, Singh R, Ravichandiran V, Swarnakar S, Ghosh D. Cas13d: A New Molecular Scissor for Transcriptome Engineering. Front Cell Dev Biol 2022;10:866800. [DOI: 10.3389/fcell.2022.866800] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Mecozzi N, Nenci A, Vera O, Bok I, Falzone A, DeNicola GM, Karreth FA. Genetic tools for the stable overexpression of circular RNAs. RNA Biol 2022;19:353-63. [PMID: 35289721 DOI: 10.1080/15476286.2022.2043041] [Reference Citation Analysis]
15 Ai Y, Liang D, Wilusz JE. CRISPR/Cas13 effectors have differing extents of off-target effects that limit their utility in eukaryotic cells. Nucleic Acids Res 2022:gkac159. [PMID: 35244715 DOI: 10.1093/nar/gkac159] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 13.0] [Reference Citation Analysis]
16 Afzal S, Hassan M, Ullah S, Abbas H, Tawakkal F, Khan MA. Breast Cancer; Discovery of Novel Diagnostic Biomarkers, Drug Resistance, and Therapeutic Implications. Front Mol Biosci 2022;9:783450. [DOI: 10.3389/fmolb.2022.783450] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
17 Yarmishyn AA, Ishola AA, Chen CY, Verusingam ND, Rengganaten V, Mustapha HA, Chuang HK, Teng YC, Phung VL, Hsu PK, Lin WC, Ma HI, Chiou SH, Wang ML. Circular RNAs Modulate Cancer Hallmark and Molecular Pathways to Support Cancer Progression and Metastasis. Cancers (Basel) 2022;14:862. [PMID: 35205610 DOI: 10.3390/cancers14040862] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
18 Lo N, Xu X, Soares F, He HH. The Basis and Promise of Programmable RNA Editing and Modification. Front Genet 2022;13:834413. [DOI: 10.3389/fgene.2022.834413] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Li L, Duan C, Weng J, Qi X, Liu C, Li X, Zhu J, Xie C. A field-deployable method for single and multiplex detection of DNA or RNA from pathogens using Cas12 and Cas13. Sci China Life Sci 2021. [PMID: 34962615 DOI: 10.1007/s11427-021-2028-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
20 Modell AE, Lim D, Nguyen TM, Sreekanth V, Choudhary A. CRISPR-based therapeutics: current challenges and future applications. Trends Pharmacol Sci 2021:S0165-6147(21)00215-7. [PMID: 34952739 DOI: 10.1016/j.tips.2021.10.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
21 Kristensen LS, Jakobsen T, Hager H, Kjems J. The emerging roles of circRNAs in cancer and oncology. Nat Rev Clin Oncol 2021. [PMID: 34912049 DOI: 10.1038/s41571-021-00585-y] [Cited by in Crossref: 47] [Cited by in F6Publishing: 55] [Article Influence: 47.0] [Reference Citation Analysis]
22 Hazan J, Bester AC. CRISPR-Based Approaches for the High-Throughput Characterization of Long Non-Coding RNAs. Noncoding RNA 2021;7:79. [PMID: 34940760 DOI: 10.3390/ncrna7040079] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Ai Y, Liang D, Wilusz JE. CRISPR/Cas13 effectors have differing extents of off-target effects that limit their utility in eukaryotic cells.. [DOI: 10.1101/2021.11.04.467323] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
24 Xiao W, Li J, Hu J, Wang L, Huang JR, Sethi G, Ma Z. Circular RNAs in cell cycle regulation: Mechanisms to clinical significance. Cell Prolif 2021;:e13143. [PMID: 34672397 DOI: 10.1111/cpr.13143] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
25 Kordyś M, Sen R, Warkocki Z. Applications of the versatile CRISPR-Cas13 RNA targeting system. Wiley Interdiscip Rev RNA 2021;:e1694. [PMID: 34553495 DOI: 10.1002/wrna.1694] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
26 Cheng X, Li Z, Shan R, Li Z, Chao L, Peng J, Fei T, Li W. Modeling CRISPR-Cas13d on-target and off-target effects using machine learning approaches.. [DOI: 10.1101/2021.09.02.458773] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Mecozzi N, Vera O, Karreth FA. Squaring the circle: circRNAs in melanoma. Oncogene 2021. [PMID: 34331015 DOI: 10.1038/s41388-021-01977-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
28 Sun W, Zhou H, Han X, Hou L, Xue X. Circular RNA: A novel type of biomarker for glioma (Review). Mol Med Rep 2021;24:602. [PMID: 34165178 DOI: 10.3892/mmr.2021.12240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Palaz F, Kalkan AK, Can Ö, Demir AN, Tozluyurt A, Özcan A, Ozsoz M. CRISPR-Cas13 System as a Promising and Versatile Tool for Cancer Diagnosis, Therapy, and Research. ACS Synth Biol 2021;10:1245-67. [PMID: 34037380 DOI: 10.1021/acssynbio.1c00107] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 15.0] [Reference Citation Analysis]
30 He AT, Liu J, Li F, Yang BB. Targeting circular RNAs as a therapeutic approach: current strategies and challenges. Signal Transduct Target Ther 2021;6:185. [PMID: 34016945 DOI: 10.1038/s41392-021-00569-5] [Cited by in Crossref: 70] [Cited by in F6Publishing: 80] [Article Influence: 70.0] [Reference Citation Analysis]
31 Krishnamoorthy A, Kadener S. Using Drosophila to uncover molecular and physiological functions of circRNAs. Methods 2021:S1046-2023(21)00108-0. [PMID: 33901645 DOI: 10.1016/j.ymeth.2021.04.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
32 Dodbele S, Mutlu N, Wilusz JE. Best practices to ensure robust investigation of circular RNAs: pitfalls and tips. EMBO Rep 2021;22:e52072. [PMID: 33629517 DOI: 10.15252/embr.202052072] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 18.0] [Reference Citation Analysis]
33 Sarkar D, Diermeier SD. Circular RNAs: Potential Applications as Therapeutic Targets and Biomarkers in Breast Cancer. Noncoding RNA 2021;7:2. [PMID: 33466455 DOI: 10.3390/ncrna7010002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]